Neurocrine Bioscienc (NASDAQ: NBIX)
| Last Price | $52.15 |
| Net Change | $-0.97 (-1.83%) |
| Bid | $0 |
| Ask Price | $0 |
| Open Price | $53 |
| Previous Close Price | $53.12 |
| High Price | $53.78 |
| Low Price | $52.07 |
| Number of Trades | 4,241 |
| Volume | 778,000 |
| Fifty Two Week High | $55.38 (2017-05-02) |
| Fifty Two Week Low | $37.35 (2016-12-29) |
| Average Daily Volume | 1,203,419 |
| Share Outstanding | 88,070 Shares |
| Total Dividend Payout | 0/yr |
| Dividend Yield | 0% |
| 1st Quarter Earnings | $-0.68 (2017-08-03) |
| 2nd Quarter Earnings | $-0.9 (2017-05-09) |
| 3nd Quarter Earnings | $-0.51 (2017-02-14) |
| 4th Quarter Earnings | $-0.43 (2016-11-02) |
| PE Ratio | $0 |
| EPS Growth | $-50.2 |
| Recent Earnings | $-0.68 |
| Annual EPS | $-2.52 |
| Last Quarter EPS | $ |
| Market Capitalization | $4.72B |
| Insider Shareholders % | 0.048% |
| Annual Revenue | $0B |
| No. Shares Outstanding | 88,070 |
| Inst. Shareholder % | 95.87% |
| Annual Net Income | $-0.22B |
| TTM Net Profit Margin | $-3467.98 |
| 1-Year Return | 12.22% |
| 3-Year Return | 239.57% |
| 5-Year Return | 613.05% |
| 5-Year Revenue Growth | -80.62% |
| 5-Year Earnings Growth | -343.28% |
| 5-Year Dividend Growth | 0% |
| Annual Dividend | $0 |
| Annual Dividend Yield | 0% |
| Change in EPS YTD | -50.200001% |
| Dividends per Share | $ |
| Stock Split Ratio | |
| Beta | 0.42 |
NBIX News & Stock Updates
August 18, 2017
3 Biotech Stocks to Buy Now for Gains Up to 93%August 4, 2017
3 of the Top Pharmaceutical Stocks to Buy NowJuly 19, 2017
3 Biotech Stocks to Watch in 2017July 13, 2017
3 of the Best Biotech Stocks to Buy NowJuly 6, 2017
3 Biotech Stocks to Buy Now for Up to 270% Growth